Another example is miR-29b, which targets DNMT3b [186] and MCL1 and is remarkably downregulated in lung [187], prostate [188], bladder [189], and ovarian cancers [190], as well as glioblastomas [191]. This evidence concerns the gene MCL1 and glioblastoma.